Differential protein expression in EC304 gastric cancer cells induced by alphastatin

Asian Pac J Cancer Prev. 2012;13(4):1667-74. doi: 10.7314/apjcp.2012.13.4.1667.

Abstract

Objective: To explore the differential protein expression profile in EC304 gastric cancer cells induced by alphastatin.

Methods: Cultured EC304 cells in the exponential phase of growth were randomly divided into alphastatin and control groups. Total proteins were extracted and the two dimensional electrophoresis (2-DE) technique was applied to analyze differences in expression with ImageMaster 2D Platinum 5.0 software. Proteins were identified using the MASCOT database and selected differently expressed proteins were characterised by western blotting and immunofluorescence.

Results: 1350 ± 90 protein spots were detected by the ImageMaster software in the 2-DE gel images from the control and alphastatin groups. The match rate was about 72-80% for the spectrum profiles, with 29 significantly different protein spots being identified, 10 upregulated, 16 downregulated, two new and one lost. The MASCOT search scores were 64-666 and the peptide matching numbers were 3-27 with sequence coverage of 8-62%. Twenty-three proteins were checked by mass spectrometry, including decrease in Nm23 and profilin-2 isoform b associated with the regulation of actin multimerisation induced by extracellular signals.

Conclusion: The proteome in EC304 cells is dramatically altered by alphastatin, which appears to play an important role in modulating cellular activity and anti-angiogenesis by regulating protein expression and signal transduction pathways through Nm23 and profilin-2 isoform b, providing new research directions for anti-angiogenic therapy of gastric cancer.

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / pharmacology*
  • Cells, Cultured
  • Down-Regulation / drug effects
  • Fibrinogen / administration & dosage
  • Fibrinogen / pharmacology*
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • NM23 Nucleoside Diphosphate Kinases / metabolism
  • Neovascularization, Physiologic / drug effects
  • Profilins / metabolism
  • Protein Biosynthesis / drug effects*
  • Stomach Neoplasms / metabolism*
  • Up-Regulation / drug effects
  • rho Guanine Nucleotide Dissociation Inhibitor alpha / drug effects
  • rho Guanine Nucleotide Dissociation Inhibitor alpha / metabolism

Substances

  • Angiogenesis Inhibitors
  • NM23 Nucleoside Diphosphate Kinases
  • PFN2 protein, human
  • Profilins
  • alphastatin
  • rho Guanine Nucleotide Dissociation Inhibitor alpha
  • Fibrinogen
  • NME1 protein, human